Modified Mucosal Advancement Flap Combined With De-Epithelialized Mucosal Flap for Labia Minora Hypertrophy

This study aimed to explore a novel and effective modified technique for the improvement in labia minora hypertrophy.

From January 2020 to December 2022, 25 patients with labia minora hypertrophy underwent surgical treatment using a modified mucosal advancement flap combined with a de-epithelialized mucosal flap for labia minora reduction. Postoperative follow-up ranged from 3 to 12 months.

No hematoma or other adverse complications were observed in all 25 patients. All patients achieved good recovery and were satisfied with the postoperative appearance and function.

Surgical treatment using a modified mucosal advancement flap combined with a de-epithelialized mucosal flap is an effective method for labia minora hypertrophy with minimal neurovascular injury, a high rate of satisfaction with the postoperative appearance, and a low complication rate.

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.